CRISPR sparked major breakthroughs and investment, but hype created a biotech bubble that has since faltered, leaving some patients without promised treatments.
CRISPR sparked major breakthroughs and investment, but hype created a biotech bubble that has since faltered, leaving some patients without promised treatments.